Recombinant ACPP antibody (AA 1-100)

Catalog No. ABIN7867785

The Rabbit Monoclonal anti-ACPP antibody is suitable to detect ACPP in samples from Human. It has been validated for IHC (p).

Quick Overview for Recombinant ACPP antibody (AA 1-100) (ABIN7867785)

Target: ACPP (Acid Phosphatase, Prostate (ACPP))

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Rabbit

Clonality: Monoclonal

Conjugate: This ACPP antibody is un-conjugated

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Grade: Carrier-free

Clone: ACPP-4495R

Product Details anti-ACPP Antibody

Binding Specificity: AA 1-100

Purpose: Prostatic acid phosphatase Antibody / PAP / PSAP / ACP3 (azide and preservative free)

Purification: Protein A/G affinity

Immunogen: A recombinant partial protein sequence (within amino acids 1-100) from the human protein was used as the immunogen for the Prostatic acid phosphatase antibody.

Isotype: IgG, kappa

Application Details

Application Notes: Optimal dilution of the Prostatic acid phosphatase antibody should be determined by the researcher.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Preservative: Azide free

Storage: -20 °C

Storage Comment: Aliquot the Prostatic acid phosphatase antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Target Details for ACPP

Target: ACPP (Acid Phosphatase, Prostate (ACPP))

Alternative Name: Prostatic acid phosphatase

Background: Prostatic Acid Phosphatase (PSAP or PAP) is a member of the histidine acid phosphatase family. It is a non-specific phosphatase that is capable of dephosphorylating tyrosine residues as well as phospholipids under mildly acidic conditions. Prostatic specific acid phosphatase (PSAP) is involved in prostate epithelial differentiation. It is highly expressed in prostate, primary and metastatic carcinoma of the prostate. This marker may be helpful in pinpointing the site of origin in cases of metastatic carcinoma of the prostate, and is considered a more sensitive marker than PSA.

UniProt: P15309

Pathways: Synaptic Membrane, Ribonucleoside Biosynthetic Process